Seeking Alpha

Ocera Therapeutics names a new CFO

  • Ocera Therapeutics (OCRX +2.4%) says it's appointed Jeryl L. Hilleman as its new CFO, effective immediately.
  • Hilleman replaces Dana McGowan, who will continue with the company during a transition period in which the company plans to move its headquarters to Northern California.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: